Clinical Trial Update: Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating a challenge dose of Engerix-B in individuals previously vaccinated against Hepatitis B; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2009-07-08